HNMPA-(AM)3 is a cell-permeable inhibitor of insulin receptor tyrosine kinase activity, blocking PTTH-stimulated ERK phosphorylation and ecdysteroidogenesis. It is utilized in insect endocrinology and comparative signaling research, with applications in both in vitro and in vivo studies to investigate insulin-related pathways in development and metabolism.
